Dexterra Group Statistics
Total Valuation
Dexterra Group has a market cap or net worth of 350.44 million. The enterprise value is 412.10 million.
| Market Cap | 350.44M |
| Enterprise Value | 412.10M |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | Mar 31, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.42% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 30.41M |
Valuation Ratios
The trailing PE ratio is 25.38.
| PE Ratio | 25.38 |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 5.35 |
| P/FCF Ratio | 12.44 |
| P/OCF Ratio | 7.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.61, with an EV/FCF ratio of 14.63.
| EV / Earnings | 29.84 |
| EV / Sales | 0.57 |
| EV / EBITDA | 5.61 |
| EV / EBIT | 8.57 |
| EV / FCF | 14.63 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.24 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 2.10 |
| Interest Coverage | 5.14 |
Financial Efficiency
Return on equity (ROE) is 13.27% and return on invested capital (ROIC) is 10.92%.
| Return on Equity (ROE) | 13.27% |
| Return on Assets (ROA) | 7.41% |
| Return on Invested Capital (ROIC) | 10.92% |
| Return on Capital Employed (ROCE) | 17.66% |
| Revenue Per Employee | 85,461 |
| Profits Per Employee | 1,693 |
| Employee Count | 8,157 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 36.01 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +29.27% in the last 52 weeks. The beta is 1.04, so Dexterra Group's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +29.27% |
| 50-Day Moving Average | 4.79 |
| 200-Day Moving Average | 5.07 |
| Relative Strength Index (RSI) | 58.53 |
| Average Volume (20 Days) | 910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dexterra Group had revenue of 697.11 million and earned 13.81 million in profits. Earnings per share was 0.21.
| Revenue | 697.11M |
| Gross Profit | 111.22M |
| Operating Income | 46.64M |
| Pretax Income | 37.28M |
| Net Income | 13.81M |
| EBITDA | 71.11M |
| EBIT | 46.64M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 59.16M |
| Net Cash | -59.16M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 193.87M |
| Book Value Per Share | 3.06 |
| Working Capital | 23.77M |
Cash Flow
In the last 12 months, operating cash flow was 46.51 million and capital expenditures -18.34 million, giving a free cash flow of 28.17 million.
| Operating Cash Flow | 46.51M |
| Capital Expenditures | -18.34M |
| Free Cash Flow | 28.17M |
| FCF Per Share | n/a |
Margins
Gross margin is 15.95%, with operating and profit margins of 6.69% and 1.98%.
| Gross Margin | 15.95% |
| Operating Margin | 6.69% |
| Pretax Margin | 5.35% |
| Profit Margin | 1.98% |
| EBITDA Margin | 10.20% |
| EBIT Margin | 6.69% |
| FCF Margin | 4.04% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 4.55%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 4.55% |
| Dividend Growth (YoY) | -3.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 112.98% |
| Buyback Yield | 1.42% |
| Shareholder Yield | 5.97% |
| Earnings Yield | 3.94% |
| FCF Yield | 8.04% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Dexterra Group has an Altman Z-Score of 3.49.
| Altman Z-Score | 3.49 |
| Piotroski F-Score | n/a |